Irena Dajić
Biographic Data
| ID | 7955252 |
|---|---|
| NAME | Irena Dajić |
| GIVEN NAMES | Irena |
| FAMILY NAME | Dajić |
| SIGNATURE | DAJIĆ I |
| AFFILIATIONS | Vienna General Hospital |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Ketamine for negative and depressive symptoms in schizophrenia
Schizophrenia (SCZ) is a severe psychiatric condition characterized by positive symptoms such as hallucinations or delusions, as well as negative symptoms such as apathy, anhedonia and avolition. Given their chronic nature and limited response to current treatments, managing negative symptoms is a significant challenge for healthcare providers. Furthermore, many individuals with SCZ suffer from depressive symptoms during the course of their illne…
Navigating the complex landscape of benzodiazepine- and Z-drug diversity
We found a multifaceted FAERS picture, and suggest that more thorough clinical and pharmacoepidemiologic investigations of the heterogenous side effect profiles for benzodiazepines and Z-drugs are needed. This may lead to more differentiated safety profiles and prescription practice for particular compounds, which in turn could potentially ease side effect burden in everyday clinical practice considerably. From both preclinical literature and pha…
No prominent works on this page.
Navigating the complex landscape of benzodiazepine- and Z-drug diversity
We found a multifaceted FAERS picture, and suggest that more thorough clinical and pharmacoepidemiologic investigations of the heterogenous side effect profiles for benzodiazepines and Z-drugs are needed. This may lead to more differentiated safety profiles and prescription practice for particular compounds, which in turn could potentially ease side effect burden in everyday clinical practice considerably. From both preclinical literature and pha…
Ketamine for negative and depressive symptoms in schizophrenia
Schizophrenia (SCZ) is a severe psychiatric condition characterized by positive symptoms such as hallucinations or delusions, as well as negative symptoms such as apathy, anhedonia and avolition. Given their chronic nature and limited response to current treatments, managing negative symptoms is a significant challenge for healthcare providers. Furthermore, many individuals with SCZ suffer from depressive symptoms during the course of their illne…
Adverse effect (1 work) · Adverse Event Reporting System (1 work) · Anhedonia (1 work) · Antidepressant (1 work) · Benzodiazepine (1 work) · Computational Drug Discovery Methods (1 work) · Depression (economics (1 work) · Depressive symptoms (1 work) · Dissociative (1 work) · Drug (1 work)